PT  - JOURNAL ARTICLE
AU  - Yair Blumberg
AU  - Michael Edelstein
AU  - Kamal Abu Jabal
AU  - Ron Golan
AU  - Yuval Perets
AU  - Musa Saad
AU  - Tatyana Levinas
AU  - Saleem Dabbah
AU  - Zeev Israeli
AU  - Salah Yacoubi
AU  - Alaa Abu Raya
AU  - Anat Amital
AU  - Majdi Halabi
TI  - Protective effect of BNT162b2 vaccination on aerobic capacity following mild to moderate SARS-CoV-2 infection: a cross sectional study, Israel, March-December 2021
AID  - 10.1101/2021.12.30.21268538
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2021.12.30.21268538
4099  - http://medrxiv.org/content/early/2022/01/02/2021.12.30.21268538.short
4100  - http://medrxiv.org/content/early/2022/01/02/2021.12.30.21268538.full
AB  - There is increasing evidence that patients who were infected with SARS-CoV-2 may experience adverse health outcomes months after the acute infection has resolved including reduction in aerobic capacity and fatigue. In this study, we compared aerobic capacity and exercise performance of 28 unvaccinated participants to 15 vaccinated ones who performed a symptom limited cardio-pulmonary exercise test (CPET) after acute COVID-19. We identified a significant difference in aerobic capacity between vaccinated and unvaccinated individuals, with a lower V’O2 peak percentage of predicted in the unvaccinated group. In addition, the unvaccinated group had a reduction in the peak-exercise heart rate and lower ventilation values. Our results suggest objective limitations to exercise capacity in the months following acute COVID19 illness, mitigated by vaccinationCompeting Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any external fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The ethics committee of Ziv Medical Centre approved the study, approval 0100-20-ZIVI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present work are contained in the manuscript